top of page
These tablets are distributed on a biannual basis as part of large campaigns with the aim of alleviating symptoms and preventing any long-term, irreversible consequences of schistosomiasis infection. The drug is safe, effective, and affordable, but it is not enough on its own.
Merck partnered with NALA in 2017 to enable their drug campaigns to have a greater impact. NALA has since worked to mobilize communities in Ethiopia through health education, national policy, and water, sanitation, and hygiene (WASH) solutions.
3 years into the project, there is already a decrease of over 60% in schistosomiasis prevalence among school children. Two years of the project remain with the goal of achieving an 80% reduction in the prevalence of intestinal worms.
bottom of page